Acute toxicity study of onion peel-derived gold nano-bioconjugate

Kabyashree Phukan1,2, Himangshu Sarma3, Rajlakshmi Devi3

  • 1Material Nanochemistry Laboratory, Physical Sciences Division, Institute of Advanced Study in Science and Technology, Paschim Boragaon, Garchuk, Guwahati, 781035 India.

3 Biotech
|May 15, 2023
PubMed

Insights

Onion peel-derived gold nano-bioconjugate (GNBC) shows no toxicity in mice during a 15-day study. This research confirms GNBC

Area of Science:

  • Nanomedicine
  • Toxicology
  • Bioconjugate Chemistry

Background:

  • The anti-inflammatory effects of onion peel-derived gold nano-bioconjugate (GNBC) have been previously established.
  • Assessing the in vivo toxicity of GNBC is crucial for its safe therapeutic application.

Purpose of the Study:

  • To evaluate the acute oral toxicity of onion peel-derived gold nano-bioconjugate (GNBC) in a preclinical setting.
  • To determine the safety profile of GNBC for potential therapeutic use.

Main Methods:

  • Acute oral toxicity study conducted in female mice over 15 days.
  • Assessment of mortality, clinical signs, body weight, hematological parameters, biochemical assays, and histopathological examination.
  • Determination of the lethal dose (LD50).

Main Results:

  • No mortality or abnormal complications were observed in mice treated with GNBC.
  • The lethal dose (LD50) was determined to be greater than 2000 mg/kg.
  • Hematological, biochemical, body weight, behavioral, and histopathological analyses indicated no significant toxicity.

Conclusions:

  • Onion peel-derived gold nano-bioconjugate (GNBC) demonstrates a favorable safety profile.
  • GNBC is deemed safe for therapeutic applications in vivo based on acute toxicity assessments.

Related Concept Videos